Drug conspiracy case ends in mistrial after juror gets sick - WKRN News 2

Drug conspiracy case ends in mistrial after juror gets sick

Tammy Tuttle, 46 Tammy Tuttle, 46

A trial for a high-profile drug conspiracy case ended abruptly this week.

The trial for Tammy Tuttle, 46, started on Monday in Maury County but ended in a mistrial Wednesday after one of the jurors became ill and had to leave.

Witnesses say the juror suffered a migraine.

Tuttle and her husband, Jerry, were arrested in April 2012 at their Culleoka home where investigators found more than $1 million in cash, guns and marijuana.

Jurors deliberated for three hours after testimony ended Tuesday evening.

"It got heated," according to Brent Cooper, the Maury County Assistant DA who told Nashville's News 2 the jurors could be heard arguing loudly from out in the hall. 

The jury returned to try again Wednesday morning but after several hours stopped when a female juror got sick.  

Medical personnel were called to the courthouse.  

"She didn't look well," said Cooper. He later learned from the judge the woman was the only one in the room who did not want to convict Tuttle.

The alternate jurors had already been sent home and could not be called back therefore the trial ended in a mistrial.

"It's disappointing," said Cooper who plans to try the case again January 8, 2014.

While this sort of thing is unusual, Cooper said he's had it happen two or three times before in his career.  Once a juror deliberating his case said she didn't want to be there anymore and got up and left, according to Cooper. 

Cooper said there were issues with the original indictment and this will allow his office time to possibly reinstate a charge that was dropped.

Tuttle is currently out on bond.

Her husband has been convicted on drug, money laundering and firearms charges in October.

The juror has not been identified.

Previous Story:

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and WKRN (Young Broadcasting station). All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.